In-house manufacturing in a GMP facility of a hospital represents a centralized approach to manufacturing that secures ...

Athira Pharma, Inc. (ATHA) has disclosed a new risk, in the Regulation category. Athira Pharma, Inc. faces significant ...

However, the required upgrades present significant technical and financial challenges for smaller manufacturers. Jatish Sheth ...

The "FDA Regulatory Compliance for Drug and Biotech Product Training Course" training has been added to ResearchAndMarkets.com's offering. This course will benefit professionals involved in working ...

Biocon Biologics announced that its drug substance facility in Bengaluru received a 'Voluntary Action Indicated' ...

Venus Remedies, a major pharmaceutical company, has received GMP approval from Malaysia's NPRA for its pre-filled syringe facility. This marks its first PIC/S accreditation. The company emphasizes the ...

underscores the high compliance standards and world-class quality control measures at Venus Remedies' Baddi facility. Aditi ...

Heat and Control, in Booths N-6104 and N-6106 at PACK EXPO International, will display its THS/PH210 Series metal detectors ...

Sagility India announced that it has already raised Rs 945.40 crore from anchor investors, with bidding concluding on Monday, ...

Venus Remedies’ Baddi robotic pre-filled syringe facility receives Malaysian PIC/S GMP approval: Our Bureau, Mumbai Tuesday, November 5, 2024, 12:15 Hrs [IST] Venus Remedies Lim ...

Sagility IPO, priced between ₹28 and ₹30 per share, is set to open for public subscription on November 5 and will close on ...

The report from the brokerage highlighted that the US healthcare sector is marked by complicated services, strict compliance standards ... Sagility India IPO GMP today is +0.50. This indicates ...